首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1392387

全球去肾神经市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

Global Renal Denervation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年11月01日 | 出版商:

Value Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球去肾神经市场需求预计将从 2022 年的 187.28 万美元达到 2030 年近 6,023.78 万美元的市场规模，2023-2030 年研究期间CAGR为 54.32%。

在肾去神经术（RDN）中，高频切除用于烧伤肾动脉的神经纤维。此过程可减少神经活动并降低血压。目前，去肾神经术是治疗高血压的一种安全且侵入性较小的方法，可导致永久停止服用降血压药物。肾去神经术是一种不可逆的过程。

市场动态：

根据研究结果，推动肾臟器械市场的关键因素是高血压发生率的增加和手术的长期有效性。此手术提供的优势，例如长期效果、更短的治疗时间和更高的安全性，预计将推动市场成长。替代和改进技术的可用性，例如微输液、去肾神经系统和新兴经济体增强的医疗基础设施是其他预计在研究期间推动市场成长的因素。儘管如此，肾去神经术过程仍面临一些挑战，包括该过程需要采购新设备，而新设备需要 FDA 批准，导致製程成本高且耗时。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球去肾神经市场的每个细分市场进行了包容性评估。肾去神经术产业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲地区去肾神经支配市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肾臟去神经术市场的主要参与者包括美敦力（Medtronic）、波士顿科学公司（Boston Scientific Corporation）、Kona Medical、雅培（Abbott）、CardioSonic、Renal Dynamics Limited、Ablative Solutions、Symple Surgical、ReCor Medical。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概述、历史和预测销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：去肾神经术公司的竞争格局

去肾神经市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Medtronic

公司简介
公司收入
产品
最近的发展

Boston Scientific Corporation

公司简介
公司收入
产品
最近的发展

Kona Medical

公司简介
公司收入
产品
最近的发展

Abbott

公司简介
公司收入
产品
最近的发展

CardioSonic

公司简介
公司收入
产品
最近的发展

Renal Dynamics Limited

公司简介
公司收入
产品
最近的发展

Ablative Solutions

公司简介
公司收入
产品
最近的发展

Symple Surgical

公司简介
公司收入
产品
最近的发展

ReCor Medical

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR11218375

The global demand for Renal Denervation Market is presumed to reach the market size of nearly USD 6023.78 MN by 2030 from USD 187.28 MN in 2022 with a CAGR of 54.32% under the study period 2023 - 2030.

In renal denervation (RDN), high-frequency extirpation is used to burn the nerve fibres of the renal arteries. This procedure reduces nerve activity and lowers blood pressure. Renal denervation is now preferred as a safe and less intrusive means of treating hypertension, resulting in permanent cessation of blood pressure medication. Renal denervation is an irreversible procedure.

MARKET DYNAMICS:

As per the findings, the key factors driving the renal devices market are the increased rate of hypertension and the procedure's long-term effectiveness. The advantages provided by this procedure, such as long-term effects, shorter treatment times, and increased safety, are anticipated to propel market growth. The availability of alternative and improved technology, such as micro-infusion, renal denervation systems, and enhanced healthcare infrastructure in emerging economies are other factors expected to drive the market growth during the study period. Despite this, several challenges are ahead of the renal denervation process, including that the process requires procuring the new device, which needs FDA approval, leading to a costly and time-consuming process.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of renal denervation. The growth and trends of renal denervation industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the renal denervation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Radiofrequency-Based
Ultrasound-Based
Micro-Infusion-Based

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Renal Denervation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the renal denervation market include Medtronic, Boston Scientific Corporation, Kona Medical, Abbott, CardioSonic, Renal Dynamics Limited, Ablative Solutions, Symple Surgical, ReCor Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . RENAL DENERVATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RENAL DENERVATION MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Radiofrequency-based Historic and Forecast Sales by Regions
6.5 Ultrasound-based Historic and Forecast Sales by Regions
6.6 Micro-Infusion-based Historic and Forecast Sales by Regions

7 . GLOBAL RENAL DENERVATION MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE RENAL DENERVATION COMPANIES

8.1. Renal Denervation Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF RENAL DENERVATION INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Medtronic
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Kona Medical
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Abbott
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. CardioSonic
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Renal Dynamics Limited
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Ablative Solutions
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Symple Surgical
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. ReCor Medical
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments